Measurement of antibiotic consumption: A practical guide to the use of the Anatomical Thgerapeutic Chemical classification and Definied Daily Dose system methodology in Canada.

Despite the global public health importance of resistance of microorganisms to the effects of antibiotics, and the direct relationship of consumption to resistance, little information is available concerning levels of consumption in Canadian hospitals and out-patient settings. The present paper provides practical advice on the use of administrative pharmacy data to address this need. Focus is made on the use of the Anatomical Therapeutic Chemical classification and Defined Daily Dose system. Examples of consumption data from Canadian community and hospital settings, with comparisons to international data, are used to incite interest and to propose uses of this information. It is hoped that all persons responsible for policy decisions regarding licensing, reimbursement, prescribing guidelines, formulary controls or any other structure pertaining to antimicrobial use become conversant with the concepts of population antibiotic consumption and that this paper provides them with the impetus and direction to begin accurately measuring and comparing antibiotic use in their jurisdictions.

[1]  E. Skovlund,et al.  Problems in collecting comparable national drug use data in Europe: the example of antibacterials , 2003, European Journal of Clinical Pharmacology.

[2]  O. Cars,et al.  Variation in antibiotic use in the European Union , 2001, The Lancet.

[3]  P. Parfrey,et al.  Role of diagnostic labeling in antibiotic prescription. , 2001, Canadian family physician Medecin de famille canadien.

[4]  H. Strøm,et al.  Different versions of the anatomical therapeutic chemical classification system and the defined daily dose – are drug utilisation data comparable? , 2000, European Journal of Clinical Pharmacology.

[5]  C. Metge,et al.  Antibiotic Use in a Canadian Province, 1995–1998 , 2000, The Annals of pharmacotherapy.

[6]  J. V. D. van der Meer,et al.  Antibiotic use in Dutch hospitals 1991-1996. , 2000, The Journal of antimicrobial chemotherapy.

[7]  D Guillemot,et al.  Inappropriateness and variability of antibiotic prescription among French office-based physicians. , 1998, Journal of clinical epidemiology.

[8]  J. Steiner,et al.  Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. , 1997, JAMA.

[9]  A G Mainous,et al.  Antibiotics and upper respiratory infection: do some folks think there is a cure for the common cold. , 1996, The Journal of family practice.

[10]  A. Mitchell,et al.  Profiles of antibacterial drug use in Australia and trends from 1987 to 1989: A report from the Drug Utilization Subcommittee of the Pharmaceutical Benefits Advisory Committee , 1991, The Medical journal of Australia.

[11]  N. F. Col,et al.  Estimating worldwide current antibiotic usage: report of Task Force 1. , 1987, Reviews of infectious diseases.

[12]  M. Finkel Magnitude of antibiotic use. , 1978, Annals of internal medicine.

[13]  W. Craig,et al.  Hospital use of antimicrobial drugs. Survey at 19 hospitals and results of antimicrobial control program. , 1978, Annals of internal medicine.

[14]  D. Robinson,et al.  The misuse of antibiotics for treatment of upper respiratory tract infections in children. , 1975, Pediatrics.